Serum Vitamin D Levels and Status in Thai Optic Neuritis Subjects: A Case-Control Study

Objective To measure serum total vitamin D or 25-hydroxyvitamin D [25(OH)D] levels and status in immune-based optic neuritis (ON) including neuromyelitis optica spectrum disorder (NMOSD)-ON, myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)-ON, autoimmune-ON, and idiopathic-ON and compare them with age- and sex-matched healthy controls. The secondary objective was to analyze the association between serum 25(OH)D levels and ON attack severity (nadir best-corrected visual acuity; nadir BCVA). Materials and Methods This was a single-center, case–control study. We enrolled 59 subjects (19 NMOSD-ON, 6 MOGAD-ON, 11 autoimmune-ON, 23 idiopathic-ON) diagnosed with acute immune-based ON (any ON attacks) over 11 years. Electronic medical records were reviewed and demographic data (age at sampling, sex, aquaporin-4 immunoglobulin (AQP4-IgG); myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG); other biomarkers of autoimmune disorders), ON attack severity (nadir BCVA), and serum 25(OH)D levels in the acute phase of ON were collected. Serum 25(OH)D levels of 236 age- and sex-matched healthy controls were assessed. Results Mean serum 25(OH)D levels were significantly lower in each group of immune-based ON compared with healthy controls (p < 0.001 for each ON group). However, mean serum 25(OH)D levels were not significantly different between four ON groups (NMOSD-ON, 20.18±5.90 ng/mL; MOGAD-ON, 23.07±4.94 ng/mL; autoimmune-ON, 21.14±5.29 ng/mL; idiopathic-ON, 19.56 ±5.12 ng/mL; p = 0.525). All immune-based ON subjects had vitamin D insufficiency or vitamin D deficiency. The prevalences of vitamin D insufficiency and vitamin D deficiency were significantly higher than in healthy controls in each ON group (both p < 0.05 in each ON group). No associations were observed between serum 25(OH)D levels and ON attack severity (nadir BCVA). Conclusions Thai immune-based ON subjects had lower serum 25(OH)D levels and higher prevalence of vitamin D insufficiency and vitamin D deficiency compared with age- and sex-matched healthy controls. Serum 25(OH)D levels were not associated with ON attack severity (nadir BCVA). We highly recommend that serum 25(OH)D levels be screened in all subjects with acute immune-based ON.

[1]  P. Ip,et al.  Vitamin D and Ocular Diseases: A Systematic Review , 2022, International journal of molecular sciences.

[2]  K. Vanikieti,et al.  Etiologies of Acute Optic Neuritis in Thailand: An Observational Study of 171 Patients , 2020, Clinical ophthalmology.

[3]  Seyhan Dikci,et al.  Conjunctival impression cytology and tear-film changes in cases with vitamin D deficiency , 2020, International Ophthalmology.

[4]  J. McCauley,et al.  Race and ethnicity on MS presentation and disease course , 2020, Multiple sclerosis.

[5]  M. Infantino,et al.  European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist’s point of view , 2019, Annals of the Rheumatic Diseases.

[6]  S. Oh,et al.  Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis. , 2019, Ophthalmology.

[7]  D. Gladman,et al.  2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus , 2019, Arthritis & rheumatology.

[8]  Ying Zhang,et al.  Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders , 2019, Journal of Clinical Neuroscience.

[9]  B. Weinshenker,et al.  Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders , 2018, JAMA neurology.

[10]  D. Imran,et al.  Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients. , 2018, Multiple sclerosis and related disorders.

[11]  J. Song,et al.  Are Serum Vitamin D Levels Associated With Dry Eye Disease? Results From the Study Group for Environmental Eye Disease , 2017, Journal of preventive medicine and public health = Yebang Uihakhoe chi.

[12]  Yuge Wang,et al.  Serum 25-hydroxyvitamin D3 is associated with disease status in patients with neuromyelitis optica spectrum disorders in south China , 2016, Journal of Neuroimmunology.

[13]  N. Prayoonwiwat,et al.  Vitamin D level status in Thai neuromyelitis optica patients , 2016, Journal of Neuroimmunology.

[14]  W. Wee,et al.  Low Serum 25-Hydroxyvitamin D Levels Are Associated with Dry Eye Syndrome , 2016, PloS one.

[15]  A. Traboulsee,et al.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2015, Neurology.

[16]  J. Kira,et al.  Decreased serum vitamin D levels in Japanese patients with multiple sclerosis , 2015, Journal of Neuroimmunology.

[17]  A. Vincent,et al.  Low Levels of Vitamin D in Neuromyelitis Optica Spectrum Disorder: Association with Disease Disability , 2014, PloS one.

[18]  H. Weiler,et al.  Vitamin D status positively associates with interleukin‐6 and tumour necrosis factor alpha in healthy young children (40.8) , 2014 .

[19]  Y. Shoenfeld,et al.  Vitamin D in Systemic and Organ-Specific Autoimmune Diseases , 2013, Clinical Reviews in Allergy & Immunology.

[20]  J. J. McAnany,et al.  Visual acuity changes in patients with leber congenital amaurosis and mutations in CEP290. , 2013, JAMA ophthalmology.

[21]  Vivian K. Lee,et al.  Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function , 2012, Neurobiology of Aging.

[22]  L. Criswell,et al.  American College of Rheumatology classification criteria for Sjögren's syndrome: A data‐driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort , 2012, Arthritis care & research.

[23]  W. Aekplakorn,et al.  Regional variation and determinants of vitamin D status in sunshine-abundant Thailand , 2011, BMC public health.

[24]  J. Callejas-Rubio,et al.  Vitamin D deficiency in a cohort of patients with systemic lupus erythematous from the South of Spain , 2011, Lupus.

[25]  Thomas J. Wang,et al.  Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. , 2010, Autoimmunity reviews.

[26]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[27]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[28]  G. Alarcón,et al.  Vitamin D Status and Its Associations with Disease Activity and Severity in African Americans with Recent-onset Rheumatoid Arthritis , 2010, The Journal of Rheumatology.

[29]  S. Shaftman,et al.  Vitamin D deficiency in systemic lupus erythematosus. , 2006, Autoimmunity reviews.

[30]  T. Dwyer,et al.  Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study , 2003, BMJ : British Medical Journal.

[31]  Terence Dwyer,et al.  Regional Variation in Multiple Sclerosis Prevalence in Australia and Its Association with Ambient Ultraviolet Radiation , 2001, Neuroepidemiology.

[32]  A. Edwards,et al.  Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older. , 1999, Ophthalmology.

[33]  E. Acheson,et al.  SOME COMMENTS ON THE RELATIONSHIP OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS TO LATITUDE, SOLAR RADIATION, AND OTHER VARIABLES , 1960, Acta psychiatrica Scandinavica. Supplementum.

[34]  Y. Fragoso,et al.  No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South , 2016, Arquivos de Neuro-Psiquiatria.

[35]  G. Plant,et al.  Optic neuritis , 2011, Eye.

[36]  Alessandra Lugaresi,et al.  Advances in the Immunopathogenesis of Multiple Sclerosis , 1999, Springer Milan.

[37]  M. Kiyosawa,et al.  [Incidence of acute idiopathic optic neuritis and its therapy in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)]. , 1995, Nippon Ganka Gakkai zasshi.